Cite
APA Citation
Kok, P. S., Forde, P. M., Hughes, B., Sun, Z., Brown, C., Ramalingam, S., Cook, A., Lesterhuis, W. J., Yip, S., O'Byrne, K., Pavlakis, N., Brahmer, J., Anagnostou, V., Ford, K., Fitzpatrick, K., Bricker, A., Cummins, M. M., Stockler, M., & Nowak, A. K. (2022). protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial. BMJ open, 12(1), . http://access.bl.uk/ark:/81055/vdc_100150524156.0x00001e